Search Results
Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria
Search for other papers by Peter Wolf in
Google Scholar
PubMed
Search for other papers by Alexandre Dormoy in
Google Scholar
PubMed
Search for other papers by Luigi Maione in
Google Scholar
PubMed
Search for other papers by Sylvie Salenave in
Google Scholar
PubMed
Search for other papers by Jacques Young in
Google Scholar
PubMed
Search for other papers by Peter Kamenický in
Google Scholar
PubMed
Search for other papers by Philippe Chanson in
Google Scholar
PubMed
Introduction Acromegaly results in a clinical syndrome following increased serum concentrations of growth hormone (GH) and insulin-like growth factor-1 (IGF-1). If not adequately treated, GH excess is associated with increased morbidity and
Search for other papers by Wenjun Long in
Google Scholar
PubMed
Search for other papers by Tuo Zhou in
Google Scholar
PubMed
Search for other papers by Xiuping Xuan in
Google Scholar
PubMed
Search for other papers by Qiuli Cao in
Google Scholar
PubMed
Search for other papers by Zuojie Luo in
Google Scholar
PubMed
Search for other papers by Yingfen Qin in
Google Scholar
PubMed
Search for other papers by Qin Ning in
Google Scholar
PubMed
Search for other papers by Xiaoping Luo in
Google Scholar
PubMed
Search for other papers by Xuemei Xie in
Google Scholar
PubMed
room temperature and then incubated with primary antibodies including LRP6 (1:1000 dilution; Abcam), β-catenin (1:2000 dilution; Abcam), P70S6K (1:2000 dilution; Abcam), IGF-1R (1:500 dilution; Abcam), IR (1:1000 dilution; Cell Signaling Technology
Search for other papers by Annalisa Blasetti in
Google Scholar
PubMed
Search for other papers by Valeria Castorani in
Google Scholar
PubMed
Search for other papers by Nella Polidori in
Google Scholar
PubMed
Search for other papers by Ilaria Mascioli in
Google Scholar
PubMed
Search for other papers by Francesco Chiarelli in
Google Scholar
PubMed
Search for other papers by Cosimo Giannini in
Google Scholar
PubMed
under-insulinization ( 3 ). These effects are mainly related to the role of insulin in the regulation of the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis. In fact, normal insulin secretion and adequate portal insulin levels are necessary
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Xiaohui Qi in
Google Scholar
PubMed
Search for other papers by Ping He in
Google Scholar
PubMed
Search for other papers by Huayan Yao in
Google Scholar
PubMed
Search for other papers by Huanhuan Sun in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Jiying Qi in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Min Cao in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Bin Cui in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Guang Ning in
Google Scholar
PubMed
because it is structurally modified ( 20 , 21 ). In addition to activating the insulin receptor cascade response, long-acting insulin analogs can also affect the IGF-1 receptor cascade response ( 22 ). And there is evidence from Alvaro’s study that IGF-1
Search for other papers by Shaomin Shi in
Google Scholar
PubMed
Search for other papers by Xinghua Chen in
Google Scholar
PubMed
Search for other papers by Wen Yu in
Google Scholar
PubMed
Search for other papers by Xiaolan Ke in
Google Scholar
PubMed
Search for other papers by Tean Ma in
Google Scholar
PubMed
109119 . ( https://doi.org/10.1016/j.diabres.2021.109119 ) 2 Dong R Yu JL Yu FX Yang S Qian Q & Zha Y . IGF-1/IGF-1R blockade ameliorates diabetic kidney disease through normalizing Snail 1 expression in a mouse model . American Journal
Search for other papers by Giovanni Fanni in
Google Scholar
PubMed
Search for other papers by Petros Katsogiannos in
Google Scholar
PubMed
Search for other papers by Bipasha Nandi Jui in
Google Scholar
PubMed
Search for other papers by Magnus Sundbom in
Google Scholar
PubMed
Search for other papers by Susanne Hetty in
Google Scholar
PubMed
Search for other papers by Maria J Pereira in
Google Scholar
PubMed
Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
stimulation in individuals with obesity ( 25 , 26 ). We reported higher fasting levels of GH after surgery, which is consistent with the higher IGF-1 levels that we have previously shown ( 9 ). This is in line with previous findings in individuals without
Search for other papers by Zhou Zheng in
Google Scholar
PubMed
Search for other papers by Xiuming Zhang in
Google Scholar
PubMed
Search for other papers by Fanggui Wu in
Google Scholar
PubMed
Search for other papers by Haizhen Liao in
Google Scholar
PubMed
Search for other papers by Huan Zhao in
Google Scholar
PubMed
Search for other papers by Minqi Zhang in
Google Scholar
PubMed
Search for other papers by Shangjie Liu in
Google Scholar
PubMed
can increase free androgens by inhibiting the synthesis of hepatic sex hormone-binding proteins or by binding to the insulin-like growth factor 1 (IGF-1) receptor, resulting in hyperandrogenemia ( 44 ). Given that elevated androgens in serum or ovary
Search for other papers by Clemens Kamrath in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany
Search for other papers by Alexander Eckert in
Google Scholar
PubMed
Search for other papers by Birgit Rami-Merhar in
Google Scholar
PubMed
Search for other papers by Sebastian Kummer in
Google Scholar
PubMed
Search for other papers by Martin Wabitsch in
Google Scholar
PubMed
Search for other papers by Katharina Laubner in
Google Scholar
PubMed
Search for other papers by Florian Kopp in
Google Scholar
PubMed
Search for other papers by Silvia Müther in
Google Scholar
PubMed
Search for other papers by Steffen Mühldorfer in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany
Search for other papers by Reinhard W Holl in
Google Scholar
PubMed
. Continuous subcutaneous IGF-1 therapy via insulin pump in a patient with Donohue syndrome . Journal of Pediatric Endocrinology and Metabolism 2014 27 1237 – 1241 . ( https://doi.org/10.1515/jpem-2013-0402 ) 35 Nakae J Kato M Murashita M Shinohara N
Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed
Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed
Search for other papers by Sally Abbott in
Google Scholar
PubMed
Search for other papers by Tin Chan in
Google Scholar
PubMed
Search for other papers by Sanesh Pillai in
Google Scholar
PubMed
Search for other papers by Kate Maslin in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK
Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed
Search for other papers by Barbara McGowan in
Google Scholar
PubMed
Search for other papers by Rob Andrews in
Google Scholar
PubMed
Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed
Search for other papers by Katherine McCullough in
Google Scholar
PubMed
Search for other papers by Lorraine Albon in
Google Scholar
PubMed
Search for other papers by Rachel Batterham in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Shareen Forbes in
Google Scholar
PubMed
Search for other papers by Gavin Bewick in
Google Scholar
PubMed
Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed
monoclonal antibody that is a negative allosteric modulator of the insulin receptor, it is selective to the insulin receptor and does not bind to the IGF-1 receptor. Xoma 358 was administered to 13 people with PBH in ascending dose (3 mg/kg, 6 mg/kg and 9 mg